Skip to main content
Year archive

ILYANG PHARMACEUTICAL CO.,LTD — 2026 filings

All 16 regulatory filings released by ILYANG PHARMACEUTICAL CO.,LTD (007570) in 2026, sourced directly from the official regulator.

16 Filings
2026 Period
2026 filings (16)
Filing Released Lang
분기보고서 (2026.03)
Interim / Quarterly Report Q1 2026
2026-05-15 Korean
타법인주식및출자증권취득결정
M&A Activity
2026-05-14 Korean
기타경영사항(자율공시)
Regulatory Filings
2026-04-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2026-04-06 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2026-03-26 Korean
기타경영사항(자율공시)
Governance Information
2026-03-25 Korean
기타시장안내 (유가증권시장 기업심사위원회 심의결과 및 상장유지 결정 안내)
Regulatory Filings
2026-03-25 Korean
사업보고서 (2025.12)
Audit Report / Information FY 2025
2026-03-18 Korean
기업가치제고계획(자율공시)
Capital/Financing Update
2026-03-16 Korean
감사보고서제출
Audit Report / Information FY 2025
2026-03-11 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2026-03-11 Korean
기타시장안내 (개선계획 이행 여부 심의 요청)
Regulatory Filings
2026-02-24 Korean
주주총회소집결의
AGM Information
2026-02-03 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Management Reports
2026-02-03 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount
2026-02-03 Korean
공정거래자율준수프로그램운영현황(안내공시)
Regulatory Filings
2026-02-03 Korean